Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
Saved in:
| Title: | Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials. |
|---|---|
| Authors: | Bissonnette, Robert1 (AUTHOR) rbissonnette@innovaderm.com, Warren, Richard B2,3 (AUTHOR), Pinter, Andreas4 (AUTHOR), Agner, Tove5 (AUTHOR), Gooderham, Melinda6,7 (AUTHOR), Schuttelaar, Marie L A8 (AUTHOR), Crépy, Marie-Noëlle9,10 (AUTHOR), Stingeni, Luca11 (AUTHOR), Serra-Baldrich, Esther12 (AUTHOR), Baranowski, Keith13 (AUTHOR), Korn, Sofie13 (AUTHOR), Kurvits, Merle13 (AUTHOR), Plohberger, Ursula13 (AUTHOR), Strange Vest, Natacha13 (AUTHOR), Schliemann, Sibylle14 (AUTHOR) |
| Source: | Lancet. Aug2024, Vol. 404 Issue 10451, p461-473. 13p. |
| Database: | Business Source Ultimate |
| ISSN: | 01406736 |
|---|---|
| DOI: | 10.1016/S0140-6736(24)01027-4 |
